drugset

drugset / Trial / NCT01159561

Western Equine Encephalitis Vaccine, Inactivated

NCT01159561 ↗

Phase 1 Completed 20 enrolled U.S. Army Medical Research and Development Command

NaSingle-groupOpen-labelPrevention

Summary

This study is designed to determine the safety and immunogenicity of WEE Vaccine Lot number 3-1-92.

Timeline

Start: 2010-02
Primary completion: 2011-08
Completion: 2012-03

Publications

Keshtkar-Jahromi M, Reisler RB, Haller JM, Clizbe DP, Rivard RG, Cardile AP, Pierson BC, Norris S, Saunders D, Pittman PR. The Western Equine Encephalitis Lyophilized, Inactivated Vaccine: An Update on Safety and Immunogenicity. Front Immunol. 2020 Nov 9;11:555464. doi: 10.3389/fimmu.2020.555464. eCollection 2020.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Western Equine Encephalitis Vaccine	Vaccine	0.5 ml	Subcutaneous

Indications